Global Screening for Liver Cancer Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Screening for Liver Cancer
The global Screening for Liver Cancer market size is projected to grow from US$ 8527.4 million in 2023 to US$ 14120 million in 2030; it is expected to grow at a CAGR of 7.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Screening for Liver Cancer Industry Forecast” looks at past sales and reviews total world Screening for Liver Cancer sales in 2023, providing a comprehensive analysis by region and market sector of projected Screening for Liver Cancer sales for 2024 through 2030. With Screening for Liver Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Screening for Liver Cancer industry.
This Insight Report provides a comprehensive analysis of the global Screening for Liver Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Screening for Liver Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Screening for Liver Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Screening for Liver Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Screening for Liver Cancer.
Globally, liver cancer is one of the leading causes of cancer-related deaths. According to the American Cancer Society, the incidence of liver cancer has tripled since the 1980s, and the death rate has now doubled. In the United States, about 41,260 new cases are expected to be diagnosed, while about 30,520 deaths from liver cancer are expected, according to 2022 cancer statistics. The global prevalence of liver cancer and the continuous exposure of related populations to risk factors will rapidly drive the screening and diagnostics market.
This report presents a comprehensive overview, market shares, and growth opportunities of Screening for Liver Cancer market by product type, application, key players and key regions and countries.
Segmentation by type
Screening for Liver Cancer
The global Screening for Liver Cancer market size is projected to grow from US$ 8527.4 million in 2023 to US$ 14120 million in 2030; it is expected to grow at a CAGR of 7.5% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Screening for Liver Cancer Industry Forecast” looks at past sales and reviews total world Screening for Liver Cancer sales in 2023, providing a comprehensive analysis by region and market sector of projected Screening for Liver Cancer sales for 2024 through 2030. With Screening for Liver Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Screening for Liver Cancer industry.
This Insight Report provides a comprehensive analysis of the global Screening for Liver Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Screening for Liver Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Screening for Liver Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Screening for Liver Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Screening for Liver Cancer.
Globally, liver cancer is one of the leading causes of cancer-related deaths. According to the American Cancer Society, the incidence of liver cancer has tripled since the 1980s, and the death rate has now doubled. In the United States, about 41,260 new cases are expected to be diagnosed, while about 30,520 deaths from liver cancer are expected, according to 2022 cancer statistics. The global prevalence of liver cancer and the continuous exposure of related populations to risk factors will rapidly drive the screening and diagnostics market.
This report presents a comprehensive overview, market shares, and growth opportunities of Screening for Liver Cancer market by product type, application, key players and key regions and countries.
Segmentation by type
- Hematology Test
- Imaging Test
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Berry Oncology
- New Horizon Health
- BGI
- GTH.O
- Livzon
- BNR.O
- SingLera
- Fujifilm Medical Systems U.S.A., Inc.
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers
- BD
- Illumina, Inc.
- Epigenomics AG
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Screening for Liver Cancer Market Size 2019-2030
2.1.2 Screening for Liver Cancer Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Screening for Liver Cancer Segment by Type
2.2.1 Hematology Test
2.2.2 Imaging Test
2.3 Screening for Liver Cancer Market Size by Type
2.3.1 Screening for Liver Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
2.4 Screening for Liver Cancer Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Screening for Liver Cancer Market Size by Application
2.5.1 Screening for Liver Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
3 SCREENING FOR LIVER CANCER MARKET SIZE BY PLAYER
3.1 Screening for Liver Cancer Market Size Market Share by Players
3.1.1 Global Screening for Liver Cancer Revenue by Players (2019-2024)
3.1.2 Global Screening for Liver Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Screening for Liver Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SCREENING FOR LIVER CANCER BY REGIONS
4.1 Screening for Liver Cancer Market Size by Regions (2019-2024)
4.2 Americas Screening for Liver Cancer Market Size Growth (2019-2024)
4.3 APAC Screening for Liver Cancer Market Size Growth (2019-2024)
4.4 Europe Screening for Liver Cancer Market Size Growth (2019-2024)
4.5 Middle East & Africa Screening for Liver Cancer Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Screening for Liver Cancer Market Size by Country (2019-2024)
5.2 Americas Screening for Liver Cancer Market Size by Type (2019-2024)
5.3 Americas Screening for Liver Cancer Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Screening for Liver Cancer Market Size by Region (2019-2024)
6.2 APAC Screening for Liver Cancer Market Size by Type (2019-2024)
6.3 APAC Screening for Liver Cancer Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Screening for Liver Cancer by Country (2019-2024)
7.2 Europe Screening for Liver Cancer Market Size by Type (2019-2024)
7.3 Europe Screening for Liver Cancer Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Screening for Liver Cancer by Region (2019-2024)
8.2 Middle East & Africa Screening for Liver Cancer Market Size by Type (2019-2024)
8.3 Middle East & Africa Screening for Liver Cancer Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SCREENING FOR LIVER CANCER MARKET FORECAST
10.1 Global Screening for Liver Cancer Forecast by Regions (2025-2030)
10.1.1 Global Screening for Liver Cancer Forecast by Regions (2025-2030)
10.1.2 Americas Screening for Liver Cancer Forecast
10.1.3 APAC Screening for Liver Cancer Forecast
10.1.4 Europe Screening for Liver Cancer Forecast
10.1.5 Middle East & Africa Screening for Liver Cancer Forecast
10.2 Americas Screening for Liver Cancer Forecast by Country (2025-2030)
10.2.1 United States Screening for Liver Cancer Market Forecast
10.2.2 Canada Screening for Liver Cancer Market Forecast
10.2.3 Mexico Screening for Liver Cancer Market Forecast
10.2.4 Brazil Screening for Liver Cancer Market Forecast
10.3 APAC Screening for Liver Cancer Forecast by Region (2025-2030)
10.3.1 China Screening for Liver Cancer Market Forecast
10.3.2 Japan Screening for Liver Cancer Market Forecast
10.3.3 Korea Screening for Liver Cancer Market Forecast
10.3.4 Southeast Asia Screening for Liver Cancer Market Forecast
10.3.5 India Screening for Liver Cancer Market Forecast
10.3.6 Australia Screening for Liver Cancer Market Forecast
10.4 Europe Screening for Liver Cancer Forecast by Country (2025-2030)
10.4.1 Germany Screening for Liver Cancer Market Forecast
10.4.2 France Screening for Liver Cancer Market Forecast
10.4.3 UK Screening for Liver Cancer Market Forecast
10.4.4 Italy Screening for Liver Cancer Market Forecast
10.4.5 Russia Screening for Liver Cancer Market Forecast
10.5 Middle East & Africa Screening for Liver Cancer Forecast by Region (2025-2030)
10.5.1 Egypt Screening for Liver Cancer Market Forecast
10.5.2 South Africa Screening for Liver Cancer Market Forecast
10.5.3 Israel Screening for Liver Cancer Market Forecast
10.5.4 Turkey Screening for Liver Cancer Market Forecast
10.5.5 GCC Countries Screening for Liver Cancer Market Forecast
10.6 Global Screening for Liver Cancer Forecast by Type (2025-2030)
10.7 Global Screening for Liver Cancer Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Screening for Liver Cancer Product Offered
11.1.3 Abbott Laboratories Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Information
11.2.2 Thermo Fisher Scientific, Inc. Screening for Liver Cancer Product Offered
11.2.3 Thermo Fisher Scientific, Inc. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific, Inc. Latest Developments
11.3 Berry Oncology
11.3.1 Berry Oncology Company Information
11.3.2 Berry Oncology Screening for Liver Cancer Product Offered
11.3.3 Berry Oncology Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Berry Oncology Main Business Overview
11.3.5 Berry Oncology Latest Developments
11.4 New Horizon Health
11.4.1 New Horizon Health Company Information
11.4.2 New Horizon Health Screening for Liver Cancer Product Offered
11.4.3 New Horizon Health Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 New Horizon Health Main Business Overview
11.4.5 New Horizon Health Latest Developments
11.5 BGI
11.5.1 BGI Company Information
11.5.2 BGI Screening for Liver Cancer Product Offered
11.5.3 BGI Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BGI Main Business Overview
11.5.5 BGI Latest Developments
11.6 GTH.O
11.6.1 GTH.O Company Information
11.6.2 GTH.O Screening for Liver Cancer Product Offered
11.6.3 GTH.O Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 GTH.O Main Business Overview
11.6.5 GTH.O Latest Developments
11.7 Livzon
11.7.1 Livzon Company Information
11.7.2 Livzon Screening for Liver Cancer Product Offered
11.7.3 Livzon Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Livzon Main Business Overview
11.7.5 Livzon Latest Developments
11.8 BNR.O
11.8.1 BNR.O Company Information
11.8.2 BNR.O Screening for Liver Cancer Product Offered
11.8.3 BNR.O Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BNR.O Main Business Overview
11.8.5 BNR.O Latest Developments
11.9 SingLera
11.9.1 SingLera Company Information
11.9.2 SingLera Screening for Liver Cancer Product Offered
11.9.3 SingLera Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 SingLera Main Business Overview
11.9.5 SingLera Latest Developments
11.10 Fujifilm Medical Systems U.S.A., Inc.
11.10.1 Fujifilm Medical Systems U.S.A., Inc. Company Information
11.10.2 Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Product Offered
11.10.3 Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Fujifilm Medical Systems U.S.A., Inc. Main Business Overview
11.10.5 Fujifilm Medical Systems U.S.A., Inc. Latest Developments
11.11 F. Hoffmann-La Roche Ltd.
11.11.1 F. Hoffmann-La Roche Ltd. Company Information
11.11.2 F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Product Offered
11.11.3 F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.11.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.12 Siemens Healthineers
11.12.1 Siemens Healthineers Company Information
11.12.2 Siemens Healthineers Screening for Liver Cancer Product Offered
11.12.3 Siemens Healthineers Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Siemens Healthineers Main Business Overview
11.12.5 Siemens Healthineers Latest Developments
11.13 BD
11.13.1 BD Company Information
11.13.2 BD Screening for Liver Cancer Product Offered
11.13.3 BD Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 BD Main Business Overview
11.13.5 BD Latest Developments
11.14 Illumina, Inc.
11.14.1 Illumina, Inc. Company Information
11.14.2 Illumina, Inc. Screening for Liver Cancer Product Offered
11.14.3 Illumina, Inc. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Illumina, Inc. Main Business Overview
11.14.5 Illumina, Inc. Latest Developments
11.15 Epigenomics AG
11.15.1 Epigenomics AG Company Information
11.15.2 Epigenomics AG Screening for Liver Cancer Product Offered
11.15.3 Epigenomics AG Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Epigenomics AG Main Business Overview
11.15.5 Epigenomics AG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Screening for Liver Cancer Market Size 2019-2030
2.1.2 Screening for Liver Cancer Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Screening for Liver Cancer Segment by Type
2.2.1 Hematology Test
2.2.2 Imaging Test
2.3 Screening for Liver Cancer Market Size by Type
2.3.1 Screening for Liver Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
2.4 Screening for Liver Cancer Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Screening for Liver Cancer Market Size by Application
2.5.1 Screening for Liver Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
3 SCREENING FOR LIVER CANCER MARKET SIZE BY PLAYER
3.1 Screening for Liver Cancer Market Size Market Share by Players
3.1.1 Global Screening for Liver Cancer Revenue by Players (2019-2024)
3.1.2 Global Screening for Liver Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Screening for Liver Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SCREENING FOR LIVER CANCER BY REGIONS
4.1 Screening for Liver Cancer Market Size by Regions (2019-2024)
4.2 Americas Screening for Liver Cancer Market Size Growth (2019-2024)
4.3 APAC Screening for Liver Cancer Market Size Growth (2019-2024)
4.4 Europe Screening for Liver Cancer Market Size Growth (2019-2024)
4.5 Middle East & Africa Screening for Liver Cancer Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Screening for Liver Cancer Market Size by Country (2019-2024)
5.2 Americas Screening for Liver Cancer Market Size by Type (2019-2024)
5.3 Americas Screening for Liver Cancer Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Screening for Liver Cancer Market Size by Region (2019-2024)
6.2 APAC Screening for Liver Cancer Market Size by Type (2019-2024)
6.3 APAC Screening for Liver Cancer Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Screening for Liver Cancer by Country (2019-2024)
7.2 Europe Screening for Liver Cancer Market Size by Type (2019-2024)
7.3 Europe Screening for Liver Cancer Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Screening for Liver Cancer by Region (2019-2024)
8.2 Middle East & Africa Screening for Liver Cancer Market Size by Type (2019-2024)
8.3 Middle East & Africa Screening for Liver Cancer Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SCREENING FOR LIVER CANCER MARKET FORECAST
10.1 Global Screening for Liver Cancer Forecast by Regions (2025-2030)
10.1.1 Global Screening for Liver Cancer Forecast by Regions (2025-2030)
10.1.2 Americas Screening for Liver Cancer Forecast
10.1.3 APAC Screening for Liver Cancer Forecast
10.1.4 Europe Screening for Liver Cancer Forecast
10.1.5 Middle East & Africa Screening for Liver Cancer Forecast
10.2 Americas Screening for Liver Cancer Forecast by Country (2025-2030)
10.2.1 United States Screening for Liver Cancer Market Forecast
10.2.2 Canada Screening for Liver Cancer Market Forecast
10.2.3 Mexico Screening for Liver Cancer Market Forecast
10.2.4 Brazil Screening for Liver Cancer Market Forecast
10.3 APAC Screening for Liver Cancer Forecast by Region (2025-2030)
10.3.1 China Screening for Liver Cancer Market Forecast
10.3.2 Japan Screening for Liver Cancer Market Forecast
10.3.3 Korea Screening for Liver Cancer Market Forecast
10.3.4 Southeast Asia Screening for Liver Cancer Market Forecast
10.3.5 India Screening for Liver Cancer Market Forecast
10.3.6 Australia Screening for Liver Cancer Market Forecast
10.4 Europe Screening for Liver Cancer Forecast by Country (2025-2030)
10.4.1 Germany Screening for Liver Cancer Market Forecast
10.4.2 France Screening for Liver Cancer Market Forecast
10.4.3 UK Screening for Liver Cancer Market Forecast
10.4.4 Italy Screening for Liver Cancer Market Forecast
10.4.5 Russia Screening for Liver Cancer Market Forecast
10.5 Middle East & Africa Screening for Liver Cancer Forecast by Region (2025-2030)
10.5.1 Egypt Screening for Liver Cancer Market Forecast
10.5.2 South Africa Screening for Liver Cancer Market Forecast
10.5.3 Israel Screening for Liver Cancer Market Forecast
10.5.4 Turkey Screening for Liver Cancer Market Forecast
10.5.5 GCC Countries Screening for Liver Cancer Market Forecast
10.6 Global Screening for Liver Cancer Forecast by Type (2025-2030)
10.7 Global Screening for Liver Cancer Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Screening for Liver Cancer Product Offered
11.1.3 Abbott Laboratories Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Information
11.2.2 Thermo Fisher Scientific, Inc. Screening for Liver Cancer Product Offered
11.2.3 Thermo Fisher Scientific, Inc. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific, Inc. Latest Developments
11.3 Berry Oncology
11.3.1 Berry Oncology Company Information
11.3.2 Berry Oncology Screening for Liver Cancer Product Offered
11.3.3 Berry Oncology Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Berry Oncology Main Business Overview
11.3.5 Berry Oncology Latest Developments
11.4 New Horizon Health
11.4.1 New Horizon Health Company Information
11.4.2 New Horizon Health Screening for Liver Cancer Product Offered
11.4.3 New Horizon Health Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 New Horizon Health Main Business Overview
11.4.5 New Horizon Health Latest Developments
11.5 BGI
11.5.1 BGI Company Information
11.5.2 BGI Screening for Liver Cancer Product Offered
11.5.3 BGI Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BGI Main Business Overview
11.5.5 BGI Latest Developments
11.6 GTH.O
11.6.1 GTH.O Company Information
11.6.2 GTH.O Screening for Liver Cancer Product Offered
11.6.3 GTH.O Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 GTH.O Main Business Overview
11.6.5 GTH.O Latest Developments
11.7 Livzon
11.7.1 Livzon Company Information
11.7.2 Livzon Screening for Liver Cancer Product Offered
11.7.3 Livzon Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Livzon Main Business Overview
11.7.5 Livzon Latest Developments
11.8 BNR.O
11.8.1 BNR.O Company Information
11.8.2 BNR.O Screening for Liver Cancer Product Offered
11.8.3 BNR.O Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BNR.O Main Business Overview
11.8.5 BNR.O Latest Developments
11.9 SingLera
11.9.1 SingLera Company Information
11.9.2 SingLera Screening for Liver Cancer Product Offered
11.9.3 SingLera Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 SingLera Main Business Overview
11.9.5 SingLera Latest Developments
11.10 Fujifilm Medical Systems U.S.A., Inc.
11.10.1 Fujifilm Medical Systems U.S.A., Inc. Company Information
11.10.2 Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Product Offered
11.10.3 Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Fujifilm Medical Systems U.S.A., Inc. Main Business Overview
11.10.5 Fujifilm Medical Systems U.S.A., Inc. Latest Developments
11.11 F. Hoffmann-La Roche Ltd.
11.11.1 F. Hoffmann-La Roche Ltd. Company Information
11.11.2 F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Product Offered
11.11.3 F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.11.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.12 Siemens Healthineers
11.12.1 Siemens Healthineers Company Information
11.12.2 Siemens Healthineers Screening for Liver Cancer Product Offered
11.12.3 Siemens Healthineers Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Siemens Healthineers Main Business Overview
11.12.5 Siemens Healthineers Latest Developments
11.13 BD
11.13.1 BD Company Information
11.13.2 BD Screening for Liver Cancer Product Offered
11.13.3 BD Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 BD Main Business Overview
11.13.5 BD Latest Developments
11.14 Illumina, Inc.
11.14.1 Illumina, Inc. Company Information
11.14.2 Illumina, Inc. Screening for Liver Cancer Product Offered
11.14.3 Illumina, Inc. Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Illumina, Inc. Main Business Overview
11.14.5 Illumina, Inc. Latest Developments
11.15 Epigenomics AG
11.15.1 Epigenomics AG Company Information
11.15.2 Epigenomics AG Screening for Liver Cancer Product Offered
11.15.3 Epigenomics AG Screening for Liver Cancer Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Epigenomics AG Main Business Overview
11.15.5 Epigenomics AG Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Screening for Liver Cancer Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Hematology Test
Table 3. Major Players of Imaging Test
Table 4. Screening for Liver Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Screening for Liver Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Table 7. Screening for Liver Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Screening for Liver Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Table 10. Global Screening for Liver Cancer Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Screening for Liver Cancer Revenue Market Share by Player (2019-2024)
Table 12. Screening for Liver Cancer Key Players Head office and Products Offered
Table 13. Screening for Liver Cancer Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Screening for Liver Cancer Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Screening for Liver Cancer Market Size Market Share by Regions (2019-2024)
Table 18. Global Screening for Liver Cancer Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Screening for Liver Cancer Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Screening for Liver Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Screening for Liver Cancer Market Size Market Share by Country (2019-2024)
Table 22. Americas Screening for Liver Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Table 24. Americas Screening for Liver Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Table 26. APAC Screening for Liver Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Screening for Liver Cancer Market Size Market Share by Region (2019-2024)
Table 28. APAC Screening for Liver Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Table 30. APAC Screening for Liver Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Table 32. Europe Screening for Liver Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Screening for Liver Cancer Market Size Market Share by Country (2019-2024)
Table 34. Europe Screening for Liver Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Table 36. Europe Screening for Liver Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Screening for Liver Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Screening for Liver Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Screening for Liver Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Screening for Liver Cancer
Table 45. Key Market Challenges & Risks of Screening for Liver Cancer
Table 46. Key Industry Trends of Screening for Liver Cancer
Table 47. Global Screening for Liver Cancer Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Screening for Liver Cancer Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Screening for Liver Cancer Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Screening for Liver Cancer Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Abbott Laboratories Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 52. Abbott Laboratories Screening for Liver Cancer Product Offered
Table 53. Abbott Laboratories Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Abbott Laboratories Main Business
Table 55. Abbott Laboratories Latest Developments
Table 56. Thermo Fisher Scientific, Inc. Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 57. Thermo Fisher Scientific, Inc. Screening for Liver Cancer Product Offered
Table 58. Thermo Fisher Scientific, Inc. Main Business
Table 59. Thermo Fisher Scientific, Inc. Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Thermo Fisher Scientific, Inc. Latest Developments
Table 61. Berry Oncology Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 62. Berry Oncology Screening for Liver Cancer Product Offered
Table 63. Berry Oncology Main Business
Table 64. Berry Oncology Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Berry Oncology Latest Developments
Table 66. New Horizon Health Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 67. New Horizon Health Screening for Liver Cancer Product Offered
Table 68. New Horizon Health Main Business
Table 69. New Horizon Health Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. New Horizon Health Latest Developments
Table 71. BGI Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 72. BGI Screening for Liver Cancer Product Offered
Table 73. BGI Main Business
Table 74. BGI Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. BGI Latest Developments
Table 76. GTH.O Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 77. GTH.O Screening for Liver Cancer Product Offered
Table 78. GTH.O Main Business
Table 79. GTH.O Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. GTH.O Latest Developments
Table 81. Livzon Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 82. Livzon Screening for Liver Cancer Product Offered
Table 83. Livzon Main Business
Table 84. Livzon Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Livzon Latest Developments
Table 86. BNR.O Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 87. BNR.O Screening for Liver Cancer Product Offered
Table 88. BNR.O Main Business
Table 89. BNR.O Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. BNR.O Latest Developments
Table 91. SingLera Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 92. SingLera Screening for Liver Cancer Product Offered
Table 93. SingLera Main Business
Table 94. SingLera Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. SingLera Latest Developments
Table 96. Fujifilm Medical Systems U.S.A., Inc. Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 97. Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Product Offered
Table 98. Fujifilm Medical Systems U.S.A., Inc. Main Business
Table 99. Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Fujifilm Medical Systems U.S.A., Inc. Latest Developments
Table 101. F. Hoffmann-La Roche Ltd. Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 102. F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Product Offered
Table 103. F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. F. Hoffmann-La Roche Ltd. Main Business
Table 105. F. Hoffmann-La Roche Ltd. Latest Developments
Table 106. Siemens Healthineers Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 107. Siemens Healthineers Screening for Liver Cancer Product Offered
Table 108. Siemens Healthineers Main Business
Table 109. Siemens Healthineers Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Siemens Healthineers Latest Developments
Table 111. BD Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 112. BD Screening for Liver Cancer Product Offered
Table 113. BD Main Business
Table 114. BD Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. BD Latest Developments
Table 116. Illumina, Inc. Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 117. Illumina, Inc. Screening for Liver Cancer Product Offered
Table 118. Illumina, Inc. Main Business
Table 119. Illumina, Inc. Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Illumina, Inc. Latest Developments
Table 121. Epigenomics AG Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 122. Epigenomics AG Screening for Liver Cancer Product Offered
Table 123. Epigenomics AG Main Business
Table 124. Epigenomics AG Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Epigenomics AG Latest Developments
Table 1. Screening for Liver Cancer Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Hematology Test
Table 3. Major Players of Imaging Test
Table 4. Screening for Liver Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Screening for Liver Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Table 7. Screening for Liver Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Screening for Liver Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Table 10. Global Screening for Liver Cancer Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Screening for Liver Cancer Revenue Market Share by Player (2019-2024)
Table 12. Screening for Liver Cancer Key Players Head office and Products Offered
Table 13. Screening for Liver Cancer Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Screening for Liver Cancer Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Screening for Liver Cancer Market Size Market Share by Regions (2019-2024)
Table 18. Global Screening for Liver Cancer Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Screening for Liver Cancer Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Screening for Liver Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Screening for Liver Cancer Market Size Market Share by Country (2019-2024)
Table 22. Americas Screening for Liver Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Table 24. Americas Screening for Liver Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Table 26. APAC Screening for Liver Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Screening for Liver Cancer Market Size Market Share by Region (2019-2024)
Table 28. APAC Screening for Liver Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Table 30. APAC Screening for Liver Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Table 32. Europe Screening for Liver Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Screening for Liver Cancer Market Size Market Share by Country (2019-2024)
Table 34. Europe Screening for Liver Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Table 36. Europe Screening for Liver Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Screening for Liver Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Screening for Liver Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Screening for Liver Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Screening for Liver Cancer
Table 45. Key Market Challenges & Risks of Screening for Liver Cancer
Table 46. Key Industry Trends of Screening for Liver Cancer
Table 47. Global Screening for Liver Cancer Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Screening for Liver Cancer Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Screening for Liver Cancer Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Screening for Liver Cancer Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Abbott Laboratories Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 52. Abbott Laboratories Screening for Liver Cancer Product Offered
Table 53. Abbott Laboratories Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Abbott Laboratories Main Business
Table 55. Abbott Laboratories Latest Developments
Table 56. Thermo Fisher Scientific, Inc. Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 57. Thermo Fisher Scientific, Inc. Screening for Liver Cancer Product Offered
Table 58. Thermo Fisher Scientific, Inc. Main Business
Table 59. Thermo Fisher Scientific, Inc. Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Thermo Fisher Scientific, Inc. Latest Developments
Table 61. Berry Oncology Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 62. Berry Oncology Screening for Liver Cancer Product Offered
Table 63. Berry Oncology Main Business
Table 64. Berry Oncology Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Berry Oncology Latest Developments
Table 66. New Horizon Health Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 67. New Horizon Health Screening for Liver Cancer Product Offered
Table 68. New Horizon Health Main Business
Table 69. New Horizon Health Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. New Horizon Health Latest Developments
Table 71. BGI Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 72. BGI Screening for Liver Cancer Product Offered
Table 73. BGI Main Business
Table 74. BGI Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. BGI Latest Developments
Table 76. GTH.O Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 77. GTH.O Screening for Liver Cancer Product Offered
Table 78. GTH.O Main Business
Table 79. GTH.O Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. GTH.O Latest Developments
Table 81. Livzon Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 82. Livzon Screening for Liver Cancer Product Offered
Table 83. Livzon Main Business
Table 84. Livzon Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Livzon Latest Developments
Table 86. BNR.O Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 87. BNR.O Screening for Liver Cancer Product Offered
Table 88. BNR.O Main Business
Table 89. BNR.O Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. BNR.O Latest Developments
Table 91. SingLera Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 92. SingLera Screening for Liver Cancer Product Offered
Table 93. SingLera Main Business
Table 94. SingLera Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. SingLera Latest Developments
Table 96. Fujifilm Medical Systems U.S.A., Inc. Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 97. Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Product Offered
Table 98. Fujifilm Medical Systems U.S.A., Inc. Main Business
Table 99. Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Fujifilm Medical Systems U.S.A., Inc. Latest Developments
Table 101. F. Hoffmann-La Roche Ltd. Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 102. F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Product Offered
Table 103. F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. F. Hoffmann-La Roche Ltd. Main Business
Table 105. F. Hoffmann-La Roche Ltd. Latest Developments
Table 106. Siemens Healthineers Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 107. Siemens Healthineers Screening for Liver Cancer Product Offered
Table 108. Siemens Healthineers Main Business
Table 109. Siemens Healthineers Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Siemens Healthineers Latest Developments
Table 111. BD Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 112. BD Screening for Liver Cancer Product Offered
Table 113. BD Main Business
Table 114. BD Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. BD Latest Developments
Table 116. Illumina, Inc. Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 117. Illumina, Inc. Screening for Liver Cancer Product Offered
Table 118. Illumina, Inc. Main Business
Table 119. Illumina, Inc. Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Illumina, Inc. Latest Developments
Table 121. Epigenomics AG Details, Company Type, Screening for Liver Cancer Area Served and Its Competitors
Table 122. Epigenomics AG Screening for Liver Cancer Product Offered
Table 123. Epigenomics AG Main Business
Table 124. Epigenomics AG Screening for Liver Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Epigenomics AG Latest Developments
LIST OF FIGURES
Figure 1. Screening for Liver Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Screening for Liver Cancer Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Screening for Liver Cancer Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Screening for Liver Cancer Sales Market Share by Country/Region (2023)
Figure 8. Screening for Liver Cancer Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Screening for Liver Cancer Market Size Market Share by Type in 2023
Figure 10. Screening for Liver Cancer in Hospital
Figure 11. Global Screening for Liver Cancer Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Screening for Liver Cancer in Clinic
Figure 13. Global Screening for Liver Cancer Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Screening for Liver Cancer in Other
Figure 15. Global Screening for Liver Cancer Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Screening for Liver Cancer Market Size Market Share by Application in 2023
Figure 17. Global Screening for Liver Cancer Revenue Market Share by Player in 2023
Figure 18. Global Screening for Liver Cancer Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Screening for Liver Cancer Market Size 2019-2024 ($ Millions)
Figure 20. APAC Screening for Liver Cancer Market Size 2019-2024 ($ Millions)
Figure 21. Europe Screening for Liver Cancer Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Screening for Liver Cancer Market Size 2019-2024 ($ Millions)
Figure 23. Americas Screening for Liver Cancer Value Market Share by Country in 2023
Figure 24. United States Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Screening for Liver Cancer Market Size Market Share by Region in 2023
Figure 29. APAC Screening for Liver Cancer Market Size Market Share by Type in 2023
Figure 30. APAC Screening for Liver Cancer Market Size Market Share by Application in 2023
Figure 31. China Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Screening for Liver Cancer Market Size Market Share by Country in 2023
Figure 38. Europe Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Figure 39. Europe Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Figure 40. Germany Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 54. APAC Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 55. Europe Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 57. United States Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 58. Canada Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 61. China Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 62. Japan Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 63. Korea Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 65. India Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 66. Australia Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 67. Germany Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 68. France Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 69. UK Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 70. Italy Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 71. Russia Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 72. Spain Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 75. Israel Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 78. Global Screening for Liver Cancer Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Screening for Liver Cancer Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Screening for Liver Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Screening for Liver Cancer Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Screening for Liver Cancer Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Screening for Liver Cancer Sales Market Share by Country/Region (2023)
Figure 8. Screening for Liver Cancer Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Screening for Liver Cancer Market Size Market Share by Type in 2023
Figure 10. Screening for Liver Cancer in Hospital
Figure 11. Global Screening for Liver Cancer Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Screening for Liver Cancer in Clinic
Figure 13. Global Screening for Liver Cancer Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Screening for Liver Cancer in Other
Figure 15. Global Screening for Liver Cancer Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Screening for Liver Cancer Market Size Market Share by Application in 2023
Figure 17. Global Screening for Liver Cancer Revenue Market Share by Player in 2023
Figure 18. Global Screening for Liver Cancer Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Screening for Liver Cancer Market Size 2019-2024 ($ Millions)
Figure 20. APAC Screening for Liver Cancer Market Size 2019-2024 ($ Millions)
Figure 21. Europe Screening for Liver Cancer Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Screening for Liver Cancer Market Size 2019-2024 ($ Millions)
Figure 23. Americas Screening for Liver Cancer Value Market Share by Country in 2023
Figure 24. United States Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Screening for Liver Cancer Market Size Market Share by Region in 2023
Figure 29. APAC Screening for Liver Cancer Market Size Market Share by Type in 2023
Figure 30. APAC Screening for Liver Cancer Market Size Market Share by Application in 2023
Figure 31. China Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Screening for Liver Cancer Market Size Market Share by Country in 2023
Figure 38. Europe Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Figure 39. Europe Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Figure 40. Germany Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Screening for Liver Cancer Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Screening for Liver Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 54. APAC Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 55. Europe Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 57. United States Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 58. Canada Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 61. China Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 62. Japan Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 63. Korea Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 65. India Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 66. Australia Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 67. Germany Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 68. France Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 69. UK Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 70. Italy Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 71. Russia Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 72. Spain Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 75. Israel Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Screening for Liver Cancer Market Size 2025-2030 ($ Millions)
Figure 78. Global Screening for Liver Cancer Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Screening for Liver Cancer Market Size Market Share Forecast by Application (2025-2030)
